Corporate News 24-Aug-23
Gland Pharma's Dundigal unit receives Establishment Inspection Report from USFDA
Gland Pharma announced that following the ‘Good Manufacturing Practice (GMP) Inspection' by US FDA at the Company's Dundigal Facility at Hyderabad between 03 July 2023 and 14 July 2023; the Company has received Establishment Inspection Report (EIR) from the US FDA indicating closure of the inspection.
Previous News
Indices trade higher; PSU bank shares advance
( Market Commentary - Mid-Session 29-Apr-24 14:34 )
Gland Pharma appoints Srinivas Sadu as executive chairman & CEO
( Hot Pursuit - 08-Jun-24 13:23 )
Gland Pharma to hold board meeting
( Corporate News - 12-Jan-24 10:53 )
Gland Pharma to convene board meeting
( Corporate News - 29-Apr-23 10:44 )
Gland Pharma consolidated net profit rises 9.79% in the March 2022 quarter
( Results - Announcements 19-May-22 17:16 )
Gland Pharma to convene board meeting
( Corporate News - 07-Jan-23 10:22 )
Gland Pharma
( Results - Analysis 23-May-24 10:29 )
Gland Pharma to table results
( Corporate News - 09-May-24 14:47 )
Gland Pharma Ltd spurts 3.65%, up for five straight sessions
( Hot Pursuit - 05-Oct-21 13:00 )
Gland Pharma rises post conclusion of US FDA's GMP inspection at Dundigal facility
( Hot Pursuit - 14-Jul-23 12:26 )
Gland Pharma gets US FDA nod for Cetrorelix Acetate
( Hot Pursuit - 29-Apr-24 13:23 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top
